In recent years, the peptide drug discovery field has shown a high level of dynamism, with hundreds of academic groups working on this topic, the creation of new peptide-focused companies, and the consolidation of peptide business by so-called big pharmaFunding: The work in the laboratory authors was funded in part by the following: the National Research Foundation (NRF) and the University of KwaZulu-Natal (South Africa), MINECO (RTI2018-093831-B-100), and the Generalitat de Catalunya (2017 SGR 1439) (Spain).Peer reviewe